Showing results (301-310 of 329) with videos related to
Sort By:
Pageof 33
Clinical Lung Cancer|August 2, 2024
Mutations Associated With High-Grade irAEs in NSCLC Patients Receiving ImmunotherapiesMargaret R Smith, Yuezhu Wang, Caroline B Dixon, et al.The Annals of Thoracic Surgery|November 4, 1998
Results of a regional study of modes of death associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study GroupG T O'Connor, J D Birkmeyer, L J Dacey, et al.International Journal of Surgery Protocols|January 4, 2020
The NeST (neoadjuvant systemic therapy in breast cancer) study - Protocol for a prospective multi-centre cohort study to assess the current utilization and short-term outcomes of neoadjuvant systemic therapies in breast cancerG W Irwin, F Bannon, C E Coles, et al.Scientific Data|August 25, 2022
The NIMH intramural healthy volunteer dataset: A comprehensive MEG, MRI, and behavioral resourceAllison C Nugent, Adam G Thomas, Margaret Mahoney, et al.JAMA|March 20, 1996
A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study GroupG T O'Connor, S K Plume, E M Olmstead, et al.Frontiers in Psychiatry|September 18, 2025
Mindfulness, music, visual occlusion in ketamine therapy for depression: do they change outcomes? A qualitative and quantitative analysis of a randomized controlled trialMina Kheirkhah, Nastasia McDonald, Julia Aepfelbacher, et al.ACS Omega|November 11, 2024
Discovery of New Cyclic Lipodepsipeptide Orfamide N via Partnership with Middle School Students from the Boys and Girls ClubJin Yi Tan, Mario Augustinović, Ashraf M Omar, et al.BMC Cancer|January 23, 2021
The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision makingI Whitehead, G W Irwin, F Bannon, et al.Blood Advances|November 22, 2024
MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myelomaManisha Bhutani, Myra Robinson, David Foureau, et al.Cancer Research|September 9, 2024
Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung CancerMargaret R Smith, Caroline B Dixon, Yuezhu Wang, et al.Pageof 33